Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 12:31 AM
NCT ID:
NCT05092360
Pre Assignment Details:
Participants with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer were enrolled into 1 of 4 arms to receive nemvaleukin alfa (ALKS 4230) either as monotherapy or in combination with pembrolizumab or in investigator's choice chemotherapy. Study was terminated due to business and strategic decision.
Recruitment Details:
The study was conducted globally from 10 Jan 2022 to 08 May 2025.
Study:
NCT05092360
Study Brief:
Results Section:
NCT05092360